Oragenics Inc.
Organization details
- Legal name
- Oragenics Inc.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Florida
- Headquarters city
- Lakewood Ranch
- Headquarters state / province
- Florida
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- OGEN
- Primary stock exchange
- NYSE American
Identifiers
- SEC CIK
- 0001174940
- EIN
- 59-3410522
Board of directors
-
Alan W. Dunton · DirectorSince 2023
-
Bruce A. Cassidy Sr. · DirectorSince 2023
-
Charles L. Pope · DirectorSince 2023
-
Fred Telling · DirectorSince 2023
-
John P. Gandolfo · DirectorSince 2023
-
Kimberly M. Murphy · Director · CEO and PresidentSince 2023
-
Natasha Giordano · DirectorSince 2025
-
Robert C. Koski · DirectorSince 2023
Chief executives
Director election results
Annual meeting of June 29, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
77.6%
-
77.8%
Board connections
3 of this board's directors also sit on 4 other boards. 4 are in the same sector.
-
CorMedix Inc. Same sectorvia Alan W. Dunton
-
Matinas Biopharma Holdings Inc. Same sectorvia Natasha Giordano
-
Palatin Technologies Inc. Same sectorvia Alan W. Dunton
-
electroCore Inc. Same sectorvia John P. Gandolfo
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $197
- 1 sale by 1 insider
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Dec 12, 2025 | Fred Telling Director | Open-market sale | −210 | $0.94 | $197 |
| Jun 18, 2025 | Odyssey Health, Inc. 10% owner | Open-market sale | −5,044 | $4.26 | $21,487 |
| Jun 17, 2025 | Odyssey Health, Inc. 10% owner | Open-market sale | −2,000 | $4.46 | $8,920 |
| Jun 16, 2025 | Odyssey Health, Inc. 10% owner | Open-market sale | −5,000 | $4.45 | $22,250 |
| Jun 13, 2025 | Odyssey Health, Inc. 10% owner | Open-market sale | −5,000 | $4.27 | $21,350 |
| Dec 11, 2024 | Robert C. Koski Director | Derivative conversion | +5,000 | — | — |
| Dec 6, 2024 | Alan W. Dunton Director | Open-market sale | −66 | $0.36 | $24 |
| Dec 6, 2024 | Fred Telling Director | Open-market sale | −3,597 | $0.36 | $1,295 |
| Nov 30, 2023 | Fred Telling Director | Open-market sale | −3,500 | $3.57 | $12,495 |
| Aug 8, 2023 | Robert C. Koski Director | Grant or award | +25,000 | — | — |
| Aug 8, 2023 | Alan W. Dunton Director | Grant or award | +25,000 | — | — |
| Aug 8, 2023 | Huffman Janet Officer (CFO, Secretary and Treasurer) | Grant or award | +15,000 | — | — |
| Aug 8, 2023 | Charles L. Pope Director | Grant or award | +25,000 | — | — |
| Aug 8, 2023 | Kimberly M. Murphy Director, Officer (CEO and President) | Grant or award | +25,000 | — | — |
| Aug 8, 2023 | Fred Telling Director | Grant or award | +25,000 | — | — |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Oragenics Inc.
Who is the CEO of Oragenics Inc.?
Kimberly M. Murphy is Oragenics Inc.'s CEO and President.
How many directors are on Oragenics Inc.'s board?
Oragenics Inc.'s board has 8 directors: Alan W. Dunton, Bruce A. Cassidy Sr., Charles L. Pope, Fred Telling, John P. Gandolfo, Kimberly M. Murphy, Natasha Giordano and Robert C. Koski.
Are Oragenics Inc. insiders buying or selling shares?
Over the last 12 months, Oragenics Inc. insiders made no open-market purchases and sold $197 of shares in 1 sale on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="oragenics-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.